Sylebra Capital (HK)’s iHuman IH Stock Holding History

Sylebra Capital (HK)’s Portfolio IH Stock Details IH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-395,103	Closed	-$7.16M	–	26
2020 Q4	$7.16M	Buy	+395,103	New	+$8.81M	0.18%	25

Other funds holding IH

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

TAMH

Taikang Asset Management (HK) Hong Kong $1B AUM 27.37% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Sylebra Capital (HK)'s IH Position: Q1 2021 in Review

Sylebra Capital (HK) sold out of iHuman (IH) in Q1 2021, closing a stake of 395,103 shares — an estimated $7.16M sold.

Sylebra Capital (HK) first reported a position in IH in Q4 2020 and held it in 1 quarter. The position peaked at $7.16M in Q4 2020. 13 funds tracked by Wall St. Rank hold IH as of Q1 2021.

Sylebra Capital (HK) reported no remaining iHuman position as of Q1 2021 after selling out during the quarter.
Sylebra Capital (HK) sold 395,103 iHuman shares in Q1 2021, an estimated $7.16M.
Sylebra Capital (HK) first reported a position in iHuman in Q4 2020 and held it in 1 quarter.
Sylebra Capital (HK)'s iHuman position peaked at $7.16M in Q4 2020.
13 funds tracked by Wall St. Rank held iHuman as of Q1 2021.

Based on Sylebra Capital (HK)'s 13F filing for Q1 2021, filed 18 May 2021.